Ticker League

EPS (Diluted) for Vertex Pharmaceuticals (VRTX)

Latest filings through · Reported

Metric

TTM

$16.86

YoY change

-836.5%

5Y CAGR

+8.3%

Peak year (2025)

$15.32

EPS (Diluted) history chart for Vertex Pharmaceuticals (VRTX) from 1990 to 2025

Latest: $15.32

EPS (Diluted) growth chart for Vertex Pharmaceuticals (VRTX) from 1990 to 2025

Latest: -836.5%

EPS (Diluted) history table for Vertex Pharmaceuticals (VRTX) from 1990 to 2025

  • 2025$15.32-836.5%
  • 2024−$2.08-115.0%
  • 2023$13.89+8.3%
  • 2022$12.82+42.3%
  • 2021$9.01-12.4%
  • 2020$10.29+128.2%
  • 2019$4.51-44.3%
  • 2018$8.09+677.9%
  • 2017$1.04-326.1%
  • 2016−$0.46-80.1%
  • 2015−$2.31-26.4%
  • 2014−$3.14+58.6%
  • 2013−$1.98+296.0%
  • 2012−$0.50-457.1%
  • 2011$0.14-103.7%
  • 2010−$3.77+1.9%
  • 2009−$3.70+13.1%
  • 2008−$3.27+7.9%
  • 2007−$3.03+65.6%
  • 2006−$1.83-19.7%
  • 2005−$2.28+7.5%
  • 2004−$2.12-17.2%
  • 2003−$2.56+79.0%
  • 2002−$1.43+60.7%
  • 2001−$0.89+50.8%
  • 2000−$0.59-26.3%
  • 1999−$0.80+23.1%
  • 1998−$0.65+58.5%
  • 1997−$0.41-61.7%
  • 1996−$1.07+69.8%
  • 1995−$0.63+12.5%
  • 1994−$0.56-800.0%
  • 1993$0.08-122.9%
  • 1992−$0.350.0%
  • 1991−$0.35+59.1%
  • 1990−$0.22—

EPS (Diluted) values are taken from Vertex Pharmaceuticals's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About EPS (Diluted) at Vertex Pharmaceuticals (VRTX)

According to Vertex Pharmaceuticals's latest reported financial statements, the company's current diluted EPS (TTM) is $16.86. Diluted earnings per share (EPS) is net income divided by the diluted weighted-average shares outstanding over the period. It expresses profit on a per-share basis — the figure investors use to value an individual share — and accounts for potential dilution from options, RSUs, and convertible securities.

Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .

2025's annual diluted EPS for Vertex Pharmaceuticals (VRTX) came in at $15.32 – plunged 836.5% year-over-year.

Looking at the 2020–2025 (5 years) stretch, Vertex Pharmaceuticals diluted EPS compounded at +8.3% per year, with mixed annual results across the window.

Across the available history, diluted EPS reached its high of $15.32 in 2025 and its low of −$3.77 in 2010.

Vertex Pharmaceuticals EPS (Diluted) by Year

Vertex Pharmaceuticals EPS (Diluted) 2025: $15.32

In 2025, Vertex Pharmaceuticals reported diluted EPS of $15.32, plunged 836.5% below 2024. This figure represents the highest annual value in the available history.

Vertex Pharmaceuticals EPS (Diluted) 2024: −$2.08

Vertex Pharmaceuticals diluted EPS in 2024 was −$2.08, plunged 115.0% below 2023.

Vertex Pharmaceuticals EPS (Diluted) 2023: $13.89

2023's diluted EPS for Vertex Pharmaceuticals came in at $13.89, grew 8.3% from 2022.

Vertex Pharmaceuticals EPS (Diluted) 2022: $12.82

Vertex Pharmaceuticals posted diluted EPS of $12.82 in 2022, surged 42.3% from 2021.

Vertex Pharmaceuticals EPS (Diluted) 2021: $9.01

Vertex Pharmaceuticals diluted EPS in 2021 was $9.01.

See more financial history for Vertex Pharmaceuticals (VRTX). Or calculate EPS yourself.

Sector peers by EPS (Diluted)

Healthcare peers of Vertex Pharmaceuticals (VRTX), ranked by their latest diluted EPS

Frequently asked questions

Vertex Pharmaceuticals (VRTX) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation